Humana is selling its stake in an end-of-life care provider for $900 million as the Medicare Advantage giant reshapes its core strategy.

Stuck on the NYT Pips puzzle for June 11? Get full hints, answers, and a step-by-step walkthrough to match dominoes to tiles today.

Nearly a year after her acquittal, Karen Read sues two police agencies tied to the investigation into boyfriend John O'Keefe's death.

Stuck on Wordle #1818? Get expert hints, clues, and the full answer for Thursday, June 11 to keep your streak alive.

The U.S. carried out a second consecutive day of strikes on Iran as an Apache helicopter was downed near the Strait of Hormuz, with both crew surviving.

The New York Mets confirmed the passing of a longtime pitcher with a mysterious personal history, dead at 65.

From job disruption to deepfakes and scientific breakthroughs, here are the five most important AI trends shaping our world today.

Harvard biologist David Sinclair is entering the $101M XPrize with SL-100, an oral drug designed to reverse aging across the entire body.

AI agent adoption is surging. Here's what leaders need to know to navigate the hybrid human-AI workforce transformation effectively.

Harvard biologist David Sinclair plans human trials of age-reversing drugs via XPrize. Plus: five essential AI insights you need right now.

The inaugural Enhanced Games in Las Vegas let athletes dope openly. Here's what happened—and what it reveals about sports, science, and society.

The inaugural Enhanced Games in Las Vegas raised big questions about performance-enhancing drugs, human limits, and AI's real impact on jobs.